Progressive familial intrahepatic cholestasis
Dernière mise à jour 18 Aug 2020
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
Progressive familial intrahepatic cholestasis (PFIC) is a disorder that causes progressive liver disease, which typically leads to liver failure. In people with PFIC, liver cells are less able to secrete a digestive fluid called bile. The buildup of bile in liver cells causes liver disease in affected individuals.
Sélections vidéo pour Conditions génétiquesBibliothèque vidéo
Description
Progressive familial intrahepatic cholestasis (PFIC) is a disorder that causes progressive liver disease, which typically leads to liver failure. In people with PFIC, liver cells are less able to secrete a digestive fluid called bile. The buildup of bile in liver cells causes liver disease in affected individuals.
Signs and symptoms of PFIC typically begin in infancy and are related to bile buildup and liver disease. Specifically, affected individuals experience severe itching, yellowing of the skin and whites of the eyes (jaundice), failure to gain weight and grow at the expected rate (failure to thrive), high blood pressure in the vein that supplies blood to the liver (portal hypertension), and an enlarged liver and spleen (hepatosplenomegaly).
There are three known types of PFIC: PFIC1, PFIC2, and PFIC3. The types are also sometimes described as shortages of particular proteins needed for normal liver function. Each type has a different genetic cause.
In addition to signs and symptoms related to liver disease, people with PFIC1 may have short stature, deafness, diarrhea, inflammation of the pancreas (pancreatitis), and low levels of fat-soluble vitamins (vitamins A, D, E, and K) in the blood. Affected individuals typically develop liver failure before adulthood.
The signs and symptoms of PFIC2 are typically related to liver disease only; however, these signs and symptoms tend to be more severe than those experienced by people with PFIC1. People with PFIC2 often develop liver failure within the first few years of life. Additionally, affected individuals are at increased risk of developing a type of liver cancer called hepatocellular carcinoma.
Most people with PFIC3 have signs and symptoms related to liver disease only. Signs and symptoms of PFIC3 usually do not appear until later in infancy or early childhood; rarely, people are diagnosed in early adulthood. Liver failure can occur in childhood or adulthood in people with PFIC3.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.
Related genes
Other names
ABCB11-related intrahepatic cholestasis
ABCB4-related intrahepatic cholestasis
ATP8B1-related intrahepatic cholestasis
BSEP deficiency
Byler disease
Byler syndrome
FIC1 deficiency
Low γ-GT familial intrahepatic cholestasis
MDR3 deficiency
Related patient information and medicines

Patient information leaflet
Cholestase obstétricale
Obstetric cholestasis is a rare condition. It only affects pregnant women. This slowing of the flow of bile leads to a build-up of bile and some then leaks out into the bloodstream, particularly the bil... Once in the bloodstream they can make the skin very itchy. It is also sometimes called intrahepatic cholestasis of pregnancy (ICP) and this.

Patient information leaflet
Complications de la grossesse
Severe cases of pre-eclampsia and HELLP syndrome can progress to eclampsia, which causes fits (convulsions) in addition to the symptoms of pre-eclampsia or... Read about pre-eclampsia, eclampsia and HELLP syndrome Pre-eclampsia. Obstetric cholestasis Obstetric cholestasis, also called intrahepatic cholestasis de pregnancy, is one cause of itching.

Patient information leaflet
Hypercholestérolémie familiale
Familial hypercholesterolaemia is inherited high cholesterol. I... Familial hypercholesterolaemia (FH) is called familial because it runs in the family (the other word for this is 'inherited'). Dr Krishna Vakharia , 13th September 2024 The National Institute for Health and Care Excellence (NICE) is recommending evinacumab alongside diet et other.

Patient information leaflet
Hypercholestérolémie
Cholestérol est a fat chemical (lipid) that is made in the cells in your body. Many different cells make cholesterol but cells in the liver make about a quarter of the total. You need some cholesterol to keep healthy. What is high cholesterol. Dr Yassir Javaid Cholesterol is a fat chemical (lipid) that is made in the cells in your body. Many.

Patient information leaflet
Ictère
Conditions affecting the common bile duct outside le liver. Conditions affecting the red blood cells Various conditions cause an increased rate of breakdown of red blood cells. As a result, there is more bilirubin made than usual (most bilirubin is made from the breakdown of haemoglobin within red blood cells) which then circulates in the blood..

Patient information leaflet
Évaluation du risque pour la santé cardiovasculaire
A cardiovascular health risk assessment provides an accurate estimate of your risk of developing cardiovascular disease (eg, angina, heart attack, stroke or peripheral arterial disease) over the following 10 years, and provides an opportunity for you to make any changes that will reduce this risk. Who is a person with familial.
Lectures complémentaires et références
- Progressive familial intrahepatic cholestasis; MedlinePlus, National Library of Medicine.
- A Siddiqi I, Tadi P. Progressive Familial Intrahepatic Cholestasis. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK559317/
- Amendola M, Squires JE. Pediatric Genetic Cholestatic Liver Disease Overview. 2022 Sep 15 [updated 2023 May 25]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK584020/
- Baker A, Kerkar N, Todorova L, Kamath BM, Houwen RHJ. Systematic review of progressive familial intrahepatic cholestasis. Clin Res Hepatol Gastroenterol. 2019 Feb;43(1):20-36. doi: 10.1016/j.clinre.2018.07.010. Epub 2018 Sep 17.
- Bull LN, Morotti R, Squires JE. ATP8B1 Deficiency. 2001 Oct 15 [updated 2021 Sep 9]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1297/
- Bull LN, Thompson RJ. Progressive Familial Intrahepatic Cholestasis. Clin Liver Dis. 2018 Nov;22(4):657-669. doi: 10.1016/j.cld.2018.06.003. Epub 2018 Aug 3.
- Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E. Progressive familial intrahepatic cholestasis. Orphanet J Rare Dis. 2009 Jan 8;4:1. doi: 10.1186/1750-1172-4-1.
- Hassan S, Hertel P. Overview of Progressive Familial Intrahepatic Cholestasis. Clin Liver Dis. 2022 Aug;26(3):371-390. doi: 10.1016/j.cld.2022.03.003.
- Pauli-Magnus C, Stieger B, Meier Y, Kullak-Ublick GA, Meier PJ. Enterohepatic transport of bile salts and genetics of cholestasis. J Hepatol. 2005 Aug;43(2):342-57. doi: 10.1016/j.jhep.2005.03.017. No abstract available.
- Pfister ED, Droge C, Liebe R, Stalke A, Buhl N, Ballauff A, Cantz T, Bueltmann E, Stindt J, Luedde T, Baumann U, Keitel V. Extrahepatic manifestations of progressive familial intrahepatic cholestasis syndromes: Presentation of a case series and literature review. Liver Int. 2022 May;42(5):1084-1096. doi: 10.1111/liv.15200. Epub 2022 Mar 15.
- Thompson RJ, Vilarinho S, Miquel R, Keitel V. Challenges in the diagnosis and treatment of genetic cholestasis in adults. JHEP Rep. 2025 Oct 9;8(1):101625. doi: 10.1016/j.jhepr.2025.101625. eCollection 2026 Jan.
- Vitale G, Sciveres M, Mandato C, d'Adamo AP, Di Giorgio A. Genotypes and different clinical variants between children and adults in progressive familial intrahepatic cholestasis: a state-of-the-art review. Orphanet J Rare Dis. 2025 Feb 21;20(1):80. doi: 10.1186/s13023-025-03599-2.
- Xie S, Wei S, Ma X, Wang R, He T, Zhang Z, Yang J, Wang J, Chang L, Jing M, Li H, Zhou X, Zhao Y. Genetic alterations and molecular mechanisms underlying hereditary intrahepatic cholestasis. Front Pharmacol. 2023 May 31;14:1173542. doi: 10.3389/fphar.2023.1173542. eCollection 2023.
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

